Pharmacogenomics of cancer pain treatment outcomes in Asian populations: A review
In advanced cancer, pain is a poor prognostic factor, significantly impacting patients' quality of life. It has been shown that up to 30% of cancer patients in Southeast Asian countries may receive inadequate analgesia from opioid therapy. This significant under-management of cancer pain is lar...
Saved in:
Main Authors: | Satkunananthan, Shobha Elizabeth, Suppiah, Vijayaprakash, Toh, Gaik-Theng, Yow, Hui-Yin |
---|---|
Format: | Article |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/40367/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a local warfarin dosage guideline based on pharmacogenomics and haemostatic markers
by: An, Chua Yung
Published: (2016) -
Population pharmacokinetics and dosing simulations of intravenous oxycodone for perioperative pain relief in adult surgical patients with obesity
by: Chaw, Sook Hui, et al.
Published: (2023) -
Clinical outcomes and quality of life of patients with short-term and long-term opioid therapy for the treatment of non- cancer pain
by: Abdullah Sani, Asween Rowena, et al.
Published: (2019) -
Effects of different gluteal strengthening programs on strength, pain, functional disability and balance among university students with nonspecific chronic low back pain: A randomized controlled trial
by: Lee, Kah Yi
Published: (2022) -
Optimizing antimicrobial therapy by integrating multi-omics with pharmacokinetic/pharmacodynamic models and precision dosing
by: Yow, Hui-Yin, et al.
Published: (2022)